💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Europe’s Vaccination Program Running at Half the Pace of U.S.

Published 18/03/2021, 11:40 pm
© Bloomberg. Visitors depart after being inoculated at a Covid-19 vaccination center in Poland's National Stadium in Warsaw, Poland, on Friday, March 12, 2021. Eastern Europe is struggling to contain a growing wave of coronavirus infections, even as an accelerating global vaccine rollout is raising optimism about the end of the pandemic.

(Bloomberg) -- The European Union’s Covid vaccination drive showed no sign of picking up the pace over the past week and is still running at less than half the pace of immunizations in the U.S., according to weekly figures from the European Centre for Disease Prevention and Control.

The 29 countries in the bloc and wider European Economic Area took delivery of 9.9 million doses over the week through March 14 and administered 9.1 million shots over the period, the ECDC said Thursday. That equates to about 1.3 million vaccinations a day compared to 2.5 million a day in the U.S., where the population is only about 70% as large.

The proportion of adults in the bloc who have received their first dose now stands at 9.8%, up 1.6 percentage points from the week before. The number rose by 1.7 points over the previous seven days. The data show that 4.3% of adults are now fully vaccinated, which has improved by 0.6 percentage points, the same increase as the week before.

Read More: Biden to Reach 100 Million Vaccinations Goal Six Weeks Early

Politicians across the bloc have said the program must speed up significantly if the EU is to meet its target of vaccinating at least 70% of people by the end of the summer and for restrictive economic measures to be eased. The report showed that the bloc has received 12.5 million doses that have yet to be administered, 1 million more than in the previous week.

“I’m not too concerned about the number,” Sam Fazeli, a pharmaceuticals analyst at Bloomberg Intelligence, said in a telephone interview. “You almost want to have some extra doses available, in case the next consignment doesn’t arrive and you need to give second doses. They should always have a stockpile.”

Fazeli estimated, based on conversations with pharmacists, that it may take as long as two weeks for shots to be administered once officials have taken delivery of the vaccines from the drug companies.

A separate EU document seen by Bloomberg suggested the backlog may be as much as 20 million shots. The EU has received about 70 million shots and administered around 50 million through March 16, the document showed.

©2021 Bloomberg L.P.

© Bloomberg. Visitors depart after being inoculated at a Covid-19 vaccination center in Poland's National Stadium in Warsaw, Poland, on Friday, March 12, 2021. Eastern Europe is struggling to contain a growing wave of coronavirus infections, even as an accelerating global vaccine rollout is raising optimism about the end of the pandemic.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.